UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells

British journal of cancer, 2017-06, Vol.117 (1), p.102-112

2017

Volltextzugriff (PDF)

Delayed functional maturation of human neuronal progenitor cells in vitro

Molecular and cellular neuroscience, 2011-05, Vol.47 (1), p.36-44

2011

Volltextzugriff (PDF)

CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component

Folia neuropathologica, 2012, Vol.50 (4), p.357-368

2012

Volltextzugriff (PDF)

Modelling Volume of Tissue Activated for Deep Brain Stimulation

Brain stimulation, 2015-03, Vol.8 (2), p.405-405

2015

Volltextzugriff (PDF)

Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas

Cancer letters, 2013-05, Vol.331 (2), p.131-138

2013

Volltextzugriff (PDF)

Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition

Cancer letters, 2012-12, Vol.325 (1), p.42-53

2012

Volltextzugriff (PDF)

A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity

Cell death discovery, 2020-04, Vol.6 (1), p.20-20, Article 20

2020

Volltextzugriff (PDF)

Targeting cancer stem‐like cells in glioblastoma and colorectal cancer through metabolic pathways

International journal of cancer, 2017-01, Vol.140 (1), p.10-22

2017

Volltextzugriff (PDF)

Cutting-edge advances in modeling the blood–brain barrier and tools for its reversible permeabilization for enhanced drug delivery into the brain

Cell & bioscience, 2023-07, Vol.13 (1), p.137-137, Article 137

2023

Volltextzugriff (PDF)

Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells

Journal of neuropathology and experimental neurology, 2015-09, Vol.74 (9), p.889-900

2015

Volltextzugriff (PDF)

ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres

Brain pathology (Zurich, Switzerland), 2015-11, Vol.25 (6), p.724-732

2015

Volltextzugriff (PDF)

Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells

International journal of cancer, 2016-03, Vol.138 (5), p.1246-1255

2016

Volltextzugriff (PDF)

Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy

Journal of neuropathology and experimental neurology, 2016-05, Vol.75 (5), p.388-396

2016

Volltextzugriff (PDF)

BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets

International journal of molecular sciences, 2021-04, Vol.22 (8), p.3913

2021

Volltextzugriff (PDF)

LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program

Oncotarget, 2013-07, Vol.4 (7), p.1050-1064

2013

Volltextzugriff (PDF)

Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro

Oncotarget, 2018-04, Vol.9 (32), p.22703-22716

2018

Volltextzugriff (PDF)

Coherent Structural and Functional Network Changes after Thalamic Lesions in Essential Tremor

Movement disorders, 2022-09, Vol.37 (9), p.1924-1929

2022

Volltextzugriff (PDF)

Abstract 2496: Targeting brain tumor stem cells by interfering with choline metabolism: Evidence for an EMT-choline oncometabolic network

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2496-2496

2017

Volltextzugriff (PDF)

DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets

Clinical cancer research, 2016-08, Vol.22 (15), p.3903-3914

2016

Volltextzugriff (PDF)

Abstract 2515: Pharmacological WNT-inhibition acts synergistically with chemo- and radiotherapy by overcoming treatment-resistance in glioma stem cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2515-2515

2016

Volltextzugriff (PDF)

Clinical neurotransplantation protocol for Huntington's and Parkinson's disease

Restorative neurology and neuroscience, 2013, Vol.31 (5), p.579-595

2013

Volltextzugriff (PDF)

Pharmacological WNT Inhibition Reduces Proliferation, Survival and Clonogenicity of Glioblastoma Cells

Journal of neuropathology and experimental neurology, 2015-09, Vol.74 (9), p.889-900

2015

Volltextzugriff (PDF)

Alterations in cellular metabolome after pharmacological inhibition of N otch in glioblastoma cells

International journal of cancer, 2016-03, Vol.138 (5), p.1246-1255

2016

Volltextzugriff (PDF)

Abstract 1038: ZEB1 plays a pivotal role in hypoxia-mediated increase of in vitro invasion of glioblastoma-derived cell cultures and represents a novel neural stem cell marker in early development

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1038-1038

2014

Volltextzugriff (PDF)

Activation of canonical WNT/[beta]-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition

Cancer letters, 2012-12, Vol.325 (1), p.42

2012

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells

Delayed functional maturation of human neuronal progenitor cells in vitro

CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component

Modelling Volume of Tissue Activated for Deep Brain Stimulation

Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas

Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition

A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity

Targeting cancer stem‐like cells in glioblastoma and colorectal cancer through metabolic pathways

Cutting-edge advances in modeling the blood–brain barrier and tools for its reversible permeabilization for enhanced drug delivery into the brain

Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells

ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres

Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells

Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy

BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets

LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program

Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro

Coherent Structural and Functional Network Changes after Thalamic Lesions in Essential Tremor

Abstract 2496: Targeting brain tumor stem cells by interfering with choline metabolism: Evidence for an EMT-choline oncometabolic network

DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets

Abstract 2515: Pharmacological WNT-inhibition acts synergistically with chemo- and radiotherapy by overcoming treatment-resistance in glioma stem cells

Clinical neurotransplantation protocol for Huntington's and Parkinson's disease

Pharmacological WNT Inhibition Reduces Proliferation, Survival and Clonogenicity of Glioblastoma Cells

Alterations in cellular metabolome after pharmacological inhibition of N otch in glioblastoma cells

Abstract 1038: ZEB1 plays a pivotal role in hypoxia-mediated increase of in vitro invasion of glioblastoma-derived cell cultures and represents a novel neural stem cell marker in early development

Activation of canonical WNT/[beta]-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition

Suchergebnisse filtern